Evelo Biosciences, Inc.
EVLO · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $8 | $27 | $48 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $4 | $3 | $4 |
| Total Curr. Assets | $19 | $11 | $30 | $52 |
| Property Plant & Equip (Net) | $1 | $8 | $11 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $2 | $10 | $12 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21 | $21 | $42 | $64 |
| Liabilities | – | – | – | – |
| Payables | $1 | $4 | $2 | $2 |
| Short-Term Debt | $34 | $47 | $44 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $8 | $0 | $0 |
| Other Curr. Liab. | $1 | -$1 | $4 | $2 |
| Total Curr. Liab. | $40 | $56 | $57 | $12 |
| LT Debt | $0 | $4 | $0 | $44 |
| Deferred Rev, NC | $8 | $8 | $8 | $8 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $8 | $0 | $1 |
| Total NC Liab. | $8 | $11 | $12 | $57 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $7 | $7 | $8 |
| Total Liabilities | $47 | $67 | $69 | $69 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$588 | -$576 | -$555 | -$529 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $530 | $0 | $0 |
| Total Equity | -$27 | -$46 | -$27 | -$5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21 | $21 | $42 | $64 |
| Net Debt | $17 | $43 | $16 | -$4 |